These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23996830)

  • 21. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.
    Valetti S; Mura S; Stella B; Couvreur P
    J Nanobiotechnology; 2013; 11 Suppl 1(Suppl 1):S6. PubMed ID: 24564841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.
    Jain A; Jain A; Parajuli P; Mishra V; Ghoshal G; Singh B; Shivhare US; Katare OP; Kesharwani P
    Drug Discov Today; 2018 May; 23(5):960-973. PubMed ID: 29129804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodegradable polymeric nanocarriers for pulmonary drug delivery.
    Rytting E; Nguyen J; Wang X; Kissel T
    Expert Opin Drug Deliv; 2008 Jun; 5(6):629-39. PubMed ID: 18532919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells.
    Kozielski KL; Tzeng SY; De Mendoza BA; Green JJ
    ACS Nano; 2014 Apr; 8(4):3232-41. PubMed ID: 24673565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA.
    Morsi NG; Ali SM; Elsonbaty SS; Afifi AA; Hamad MA; Gao H; Elsabahy M
    Pharm Dev Technol; 2018 Apr; 23(4):387-399. PubMed ID: 28347210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
    Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
    Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
    Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.
    Liu H; Zhu X; Wei Y; Song C; Wang Y
    Biomed Pharmacother; 2023 Jan; 157():114065. PubMed ID: 36481408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
    de Martimprey H; Vauthier C; Malvy C; Couvreur P
    Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies.
    Yoosefi S; Esfandyari-Manesh M; Ghorbani-Bidkorpeh F; Ahmadi M; Moraffah F; Dinarvand R
    Daru; 2022 Dec; 30(2):289-302. PubMed ID: 36087235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
    Xia T; Kovochich M; Liong M; Meng H; Kabehie S; George S; Zink JI; Nel AE
    ACS Nano; 2009 Oct; 3(10):3273-86. PubMed ID: 19739605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
    Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymeric nanodroplets: an emerging trend in gaseous delivery system.
    Shende P; Jain S
    J Drug Target; 2019 Dec; 27(10):1035-1045. PubMed ID: 30808239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanocarriers for microRNA delivery in cancer medicine.
    Fernandez-Piñeiro I; Badiola I; Sanchez A
    Biotechnol Adv; 2017; 35(3):350-360. PubMed ID: 28286148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.